Merck Sees Success In $2 Billion Sales Goal For China, India, Brazil

U.S. drug maker Merck says its plan to realize $2 billion in sales in China, India and Brazil is on track because its drugs match major needs in all three. CEO Richard Clark said Merck is expanding manufacturing capacity to produce more vaccines, even in the face of competition from generics. Clark said the firm has done so because it focuses on the needs of patients and doctors in those countries. He said its best sellers in the three countries are its vaccines and drugs to treat diabetes and HIV, the major health problems in the three. (Click here for more